AU748087B2
(en)
*
|
1998-02-17 |
2002-05-30 |
Tularik Inc. |
Anti-viral pyrimidine derivatives
|
AP1683A
(en)
*
|
1998-11-10 |
2006-11-29 |
Janssen Pharmaceutica Nv |
HIV replication inhibiting pyrimidines.
|
TR200101319T2
(tr)
*
|
1998-11-10 |
2001-10-22 |
Janssen Pharmaceutica N.V. |
2,4-Disübstitüe triazin türevleri.
|
CA2376951A1
(en)
|
1999-06-30 |
2001-01-04 |
Peter J. Sinclair |
Src kinase inhibitor compounds
|
JP2003503351A
(ja)
|
1999-06-30 |
2003-01-28 |
メルク エンド カムパニー インコーポレーテッド |
Srcキナーゼ阻害化合物
|
CA2383546A1
(en)
|
1999-06-30 |
2001-01-04 |
William H. Parsons |
Src kinase inhibitor compounds
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
EE04991B1
(et)
*
|
1999-09-24 |
2008-04-15 |
Janssen Pharmaceutica N.V. |
Osake, ravimvorm, nende valmistamismeetodid, osakeste kasutamine ning farmatseutiline pakend
|
DE60039059D1
(de)
|
1999-10-07 |
2008-07-10 |
Amgen Inc |
Triazin-kinase-hemmer
|
US6410726B1
(en)
|
2000-01-12 |
2002-06-25 |
Tularik Inc. |
Arylsulfonic acid salts of pyrimidine-based antiviral
|
AU3704101A
(en)
|
2000-02-17 |
2001-08-27 |
Amgen Inc |
Kinase inhibitors
|
YU63802A
(sh)
*
|
2000-02-25 |
2005-06-10 |
F. Hoffmann-La Roche Ag. |
Modulatori adenozinskih receptora
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004886D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
US7235551B2
(en)
*
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
GB0007371D0
(en)
|
2000-03-28 |
2000-05-17 |
Astrazeneca Uk Ltd |
Chemical compounds
|
CA2406562C
(en)
*
|
2000-05-08 |
2009-09-15 |
Janssen Pharmaceutica N.V. |
Hiv replication inhibiting pyrimidines and triazines
|
CA2407754C
(en)
*
|
2000-05-08 |
2009-09-15 |
Janssen Pharmaceutica N.V. |
Prodrugs of hiv replication inhibiting pyrimidines
|
GB0016877D0
(en)
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
GB0017676D0
(en)
*
|
2000-07-19 |
2000-09-06 |
Angeletti P Ist Richerche Bio |
Inhibitors of viral polymerase
|
GB0021726D0
(en)
|
2000-09-05 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
US6660731B2
(en)
*
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US7473691B2
(en)
*
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
CA2422380C
(en)
*
|
2000-09-15 |
2009-03-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
JP4524072B2
(ja)
|
2000-10-23 |
2010-08-11 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
新規化合物
|
US20050250854A1
(en)
*
|
2000-11-03 |
2005-11-10 |
Amgen Inc. |
Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
|
WO2002039958A2
(en)
*
|
2000-11-03 |
2002-05-23 |
Tularik Inc. |
Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
|
CN100340555C
(zh)
*
|
2000-12-21 |
2007-10-03 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的吡唑化合物
|
US7081470B2
(en)
|
2001-01-31 |
2006-07-25 |
H. Lundbeck A/S |
Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
|
US20040127502A1
(en)
|
2001-01-31 |
2004-07-01 |
Synaptic Pharmaceutical Corporation |
Use of GAL3 antagonist for treatment of depression
|
WO2002064096A2
(en)
*
|
2001-02-16 |
2002-08-22 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
GB0113041D0
(en)
|
2001-05-30 |
2001-07-18 |
Astrazeneca Ab |
Chemical compounds
|
US6958340B2
(en)
*
|
2001-08-01 |
2005-10-25 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
ES2250721T3
(es)
*
|
2001-09-21 |
2006-04-16 |
Sanofi-Aventis |
Derivados de 2-pirimidinil-6,7,8,9-tetrahidropirimido(1,2-a)pirimidin-4-ona y 7-pirimidinil-2,3-dihidroimidazo(1,2-a)pirimidin-5(1h)ona sustituidos para enfermedades neurodegenerativas.
|
ES2314106T3
(es)
*
|
2001-10-17 |
2009-03-16 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG |
Derivados de pirimidina, agentes farmaceuticos que contiene dichos compuestos, uso y metodo para su obtencion.
|
WO2003032994A2
(de)
|
2001-10-17 |
2003-04-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
US20040034037A1
(en)
*
|
2002-02-06 |
2004-02-19 |
Harbeson Scott L. |
Heteroaryl compounds useful as inhibitors of GSK-3
|
GB0205690D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
GB0205688D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
WO2003076434A1
(en)
|
2002-03-09 |
2003-09-18 |
Astrazeneca Ab |
4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
|
GB0205693D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
WO2003078427A1
(en)
*
|
2002-03-15 |
2003-09-25 |
Vertex Pharmaceuticals, Inc. |
Azolylaminoazines as inhibitors of protein kinases
|
KR100516434B1
(ko)
|
2002-04-04 |
2005-09-22 |
(주) 비엔씨바이오팜 |
6-(4-치환된-아닐리노)피리미딘 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
|
RU2004133811A
(ru)
|
2002-04-19 |
2005-04-20 |
Смитклайн Бичам Корпорейшн (US) |
Новые соединения
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
ES2373226T3
(es)
|
2002-06-28 |
2012-02-01 |
Astellas Pharma Inc. |
Derivado de diaminopirimidincarboxamida.
|
GB0217431D0
(en)
|
2002-07-27 |
2002-09-04 |
Astrazeneca Ab |
Novel compounds
|
DK1534286T3
(da)
|
2002-07-29 |
2010-04-26 |
Rigel Pharmaceuticals Inc |
Fremgangsmåder til behandling eller forebyggelse af autoimmune sygdomme med 2,4-pyrimidindiamin-forbindelser
|
CA2494100C
(en)
|
2002-08-02 |
2011-10-11 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of gsk-3
|
AU2003258612A1
(en)
*
|
2002-08-14 |
2004-03-03 |
4Sc Ag |
Pyrimidones as antiviral agents
|
EP1389461A1
(en)
*
|
2002-08-14 |
2004-02-18 |
Axxima Pharmaceuticals Aktiengesellschaft |
Pyrimidones with antiviral properties
|
DE10238722A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
|
ES2295685T3
(es)
|
2002-08-24 |
2008-04-16 |
Astrazeneca Ab |
Derivados de pirimidina como moduladores de la actividad del receptor de quimioquinas.
|
DE10251914A1
(de)
*
|
2002-11-08 |
2004-05-19 |
Bayer Ag |
Substituierte Chinazoline
|
US7109337B2
(en)
|
2002-12-20 |
2006-09-19 |
Pfizer Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
AU2003285614B2
(en)
|
2002-12-20 |
2009-05-14 |
Pfizer Products, Inc. |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
DE10319612A1
(de)
|
2003-05-02 |
2004-11-18 |
Bayer Healthcare Ag |
Substituierte Dihydrochinazoline
|
US7601718B2
(en)
*
|
2003-02-06 |
2009-10-13 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
US7157455B2
(en)
|
2003-02-10 |
2007-01-02 |
Hoffmann-La Roche Inc. |
4-Aminopyrimidine-5-one derivatives
|
DE10305785A1
(de)
|
2003-02-12 |
2004-08-26 |
Bayer Healthcare Ag |
Dihydrochinazoline
|
AU2004212957A1
(en)
*
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Novel compounds
|
DE10320785A1
(de)
|
2003-05-09 |
2004-11-25 |
Bayer Healthcare Ag |
6-Arylmethyl-substituierte Pyrazolopyrimidine
|
DE10320780A1
(de)
|
2003-05-09 |
2005-01-20 |
Bayer Healthcare Ag |
Heterocyclyl-substituierte Dihydrochinazoline
|
GB0311276D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
GB0311274D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
KR100502394B1
(ko)
*
|
2003-06-04 |
2005-07-19 |
(주) 비엔씨바이오팜 |
2-[2-(4-모르포리노)에틸아미노]피리딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
|
KR100502395B1
(ko)
*
|
2003-06-04 |
2005-07-19 |
(주) 비엔씨바이오팜 |
4-[4-(4-모르포리노)아닐리노]피리미딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물.
|
DE10328479A1
(de)
|
2003-06-25 |
2005-01-13 |
Bayer Ag |
6-Arylamino-5-cyano-4-pyrimidinone
|
CN1849318B
(zh)
*
|
2003-07-30 |
2011-10-12 |
里格尔药品股份有限公司 |
用2,4-嘧啶二胺化合物预防和治疗自体免疫疾病的方法
|
DE10352499A1
(de)
*
|
2003-11-11 |
2005-06-09 |
Bayer Healthcare Ag |
Substituierte Dihydrochinazoline II
|
CA2545992A1
(en)
|
2003-11-24 |
2005-06-16 |
F. Hoffmann-La Roche Ag |
Pyrazolyl and imidazolyl pyrimidines
|
EP1694671A2
(en)
*
|
2003-12-04 |
2006-08-30 |
Vertex Pharmaceuticals Incorporated |
Quinoxalines useful as inhibitors of protein kinases
|
TWI355894B
(en)
|
2003-12-19 |
2012-01-11 |
Du Pont |
Herbicidal pyrimidines
|
TW200533357A
(en)
|
2004-01-08 |
2005-10-16 |
Millennium Pharm Inc |
2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
|
TW200528101A
(en)
|
2004-02-03 |
2005-09-01 |
Astrazeneca Ab |
Chemical compounds
|
DE102004022672A1
(de)
|
2004-05-07 |
2005-11-24 |
Bayer Healthcare Ag |
Substituierte Azachinazoline
|
MXPA06013165A
(es)
|
2004-05-14 |
2007-02-13 |
Pfizer Prod Inc |
Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal.
|
JP2007537235A
(ja)
|
2004-05-14 |
2007-12-20 |
ファイザー・プロダクツ・インク |
異常細胞増殖の治療用ピリミジン誘導体
|
EP1751142A1
(en)
|
2004-05-14 |
2007-02-14 |
Pfizer Products Incorporated |
Pyrimidines derivatives for the treatment of abnormal cell growth
|
EP1598343A1
(de)
*
|
2004-05-19 |
2005-11-23 |
Boehringer Ingelheim International GmbH |
2-Arylaminopyrimidine als PLK Inhibitoren
|
RS53145B
(en)
|
2004-08-28 |
2014-06-30 |
Astrazeneca Ab. |
PIRIMIDINE SULFONAMIDE DERIVATIVES AS CHEMOKIN RECEPTOR MODULATORS
|
US7491720B2
(en)
|
2004-10-29 |
2009-02-17 |
Banyu Pharmaceutical Co., Ltd. |
Aminopyridine derivatives having Aurora A selective inhibitory action
|
KR20070086188A
(ko)
*
|
2004-11-17 |
2007-08-27 |
미카나 테라퓨틱스, 인크. |
키나제 억제제
|
US7557207B2
(en)
|
2004-11-24 |
2009-07-07 |
Rigel Pharmaceuticals, Inc. |
Spiro 2,4-pyrimidinediamine compounds and their uses
|
AU2005315392B2
(en)
*
|
2004-12-17 |
2010-03-11 |
Astrazeneca Ab |
4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as CDK inhibitors
|
US7187123B2
(en)
*
|
2004-12-29 |
2007-03-06 |
Dupont Displays, Inc. |
Display device
|
JP5208516B2
(ja)
|
2004-12-30 |
2013-06-12 |
エグゼリクシス, インコーポレイテッド |
キナーゼモジュレーターとしてのピリミジン誘導体および使用方法
|
CN101115761B
(zh)
|
2005-01-19 |
2012-07-18 |
里格尔药品股份有限公司 |
2,4-嘧啶二胺化合物的前药及其应用
|
ATE530545T1
(de)
|
2005-02-04 |
2011-11-15 |
Astrazeneca Ab |
Als kinaseinhibitoren geeignete pyrazolylaminopyridinderivate
|
NZ561525A
(en)
|
2005-02-16 |
2010-11-26 |
Astrazeneca Ab |
Benzimidazole compounds and analogues, containing a pyrazole ring, for inhibition of Trk activity, affecting cancer
|
EP1868612A4
(en)
*
|
2005-03-25 |
2010-03-24 |
Glaxo Group Ltd |
NOVEL CONNECTIONS
|
AU2006229995A1
(en)
*
|
2005-03-25 |
2006-10-05 |
Glaxo Group Limited |
Process for preparing pyrido(2,3-d)pyrimidin-7-one and 3,4-dihydropyrimido(4,5-d)pyrimidin-2(1H)-one derivatives
|
PE20061193A1
(es)
|
2005-03-25 |
2006-12-02 |
Glaxo Group Ltd |
DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
|
PE20061351A1
(es)
*
|
2005-03-25 |
2007-01-14 |
Glaxo Group Ltd |
COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
|
CA2604551A1
(en)
*
|
2005-05-03 |
2007-03-08 |
Rigel Pharmaceuticals, Inc. |
Jak kinase inhibitors and their uses
|
JP5161764B2
(ja)
|
2005-05-06 |
2013-03-13 |
イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー |
場合により2−置換されていてもよい1,6−ジヒドロ−6−オキソ−4−ピリミジンカルボン酸の製造方法
|
EP1888536B1
(en)
|
2005-05-16 |
2010-04-28 |
E.I. Du Pont De Nemours And Company |
Process for preparing substituted pyrimidines
|
WO2006123113A2
(en)
|
2005-05-16 |
2006-11-23 |
Astrazeneca Ab |
Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
|
US20070203161A1
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
US7491732B2
(en)
|
2005-06-08 |
2009-02-17 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
DE102005027517A1
(de)
|
2005-06-15 |
2006-12-21 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von Dihydrochinazolinen
|
CA2617170A1
(en)
*
|
2005-07-30 |
2007-02-08 |
Astrazeneca Ab |
Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders
|
US7737151B2
(en)
*
|
2005-08-18 |
2010-06-15 |
Vertex Pharmaceuticals Incorporated |
Pyrazine kinase inhibitors
|
CA2622352C
(en)
*
|
2005-09-30 |
2014-05-27 |
Miikana Therapeutics, Inc. |
Substituted pyrazole compounds
|
US7745428B2
(en)
|
2005-09-30 |
2010-06-29 |
Astrazeneca Ab |
Imidazo[1,2-A]pyridine having anti-cell-proliferation activity
|
DK1945631T3
(da)
|
2005-10-28 |
2012-10-22 |
Astrazeneca Ab |
4- (3-aminopyrazole) pyrimidinderivater til anvendelse som tyrosinkinaseinhibitorer til behandling af cancer
|
AU2006311830B2
(en)
|
2005-11-03 |
2013-03-14 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
UA95949C2
(ru)
|
2006-03-31 |
2011-09-26 |
Янссен Фармацевтика, Н.В. |
Бензоимидазол-2-илпиримидины и пиразины как модуляторы рецептора гистамина h4
|
TW200811169A
(en)
*
|
2006-05-26 |
2008-03-01 |
Astrazeneca Ab |
Chemical compounds
|
US8222256B2
(en)
*
|
2006-07-05 |
2012-07-17 |
Exelixis, Inc. |
Methods of using IGFIR and ABL kinase modulators
|
EP2086965B1
(en)
*
|
2006-11-02 |
2010-02-10 |
Vertex Pharmaceuticals, Inc. |
Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
|
MX2009006690A
(es)
*
|
2006-12-19 |
2009-07-31 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de proteinas cinasas.
|
WO2008111441A1
(ja)
|
2007-03-05 |
2008-09-18 |
Kyowa Hakko Kirin Co., Ltd. |
医薬組成物
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
NZ579483A
(en)
*
|
2007-03-09 |
2012-07-27 |
Vertex Pharma |
Aminopyridines useful as inhibitors of protein kinases
|
CA2679884A1
(en)
*
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
EP2137183B1
(en)
*
|
2007-03-09 |
2011-09-28 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
EP2146982A2
(en)
|
2007-04-13 |
2010-01-27 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
WO2008129380A1
(en)
|
2007-04-18 |
2008-10-30 |
Pfizer Products Inc. |
Sulfonyl amide derivatives for the treatment of abnormal cell growth
|
MX2009011811A
(es)
*
|
2007-05-02 |
2010-01-14 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de cinasa.
|
AU2008247592A1
(en)
|
2007-05-02 |
2008-11-13 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and pyrazoles useful as kinase inhibitors
|
MX2009011812A
(es)
*
|
2007-05-02 |
2010-01-14 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de cinasa.
|
UA99459C2
(en)
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
EP2164842A2
(en)
*
|
2007-05-24 |
2010-03-24 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and pyrazoles useful as kinase inhibitors
|
JP2010529193A
(ja)
*
|
2007-06-11 |
2010-08-26 |
ミイカナ セラピューティクス インコーポレイテッド |
置換ピラゾール化合物
|
EP2176261B1
(en)
*
|
2007-07-31 |
2012-12-19 |
Vertex Pharmaceuticals Incorporated |
Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
|
EA019085B1
(ru)
|
2007-09-14 |
2014-01-30 |
Янссен Фармасьютикалз, Инк. |
1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны
|
TWI475995B
(zh)
|
2007-09-14 |
2015-03-11 |
Janssen Pharmaceuticals Inc |
1’,3’-二取代-4-苯基-3,4,5,6-四氫-2h,1’h-〔1,4’〕聯吡啶基-2’-酮化物
|
JP5433579B2
(ja)
|
2007-09-14 |
2014-03-05 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド. |
1,3−二置換−4−フェニル−1h−ピリジン−2−オン
|
RU2492170C9
(ru)
|
2007-11-14 |
2013-12-27 |
Орто-Макнейл-Янссен Фармасьютикалз, Инк. |
Имидазо[1,2-а]пиридиновые производные и их применение в качестве положительных аллостерических модуляторов рецепторов mglur2
|
CA2706018C
(en)
|
2007-11-30 |
2015-11-24 |
Boehringer Ingelheim International Gmbh |
1, 5-dihydro-pyrazolo [3,4-d]pyrimidin-4-one derivatives and their use as pde9a modulators for the treatment of cns disorders
|
DE102007061756A1
(de)
|
2007-12-20 |
2009-06-25 |
Bayer Healthcare Ag |
Substituierte 4-Aminopyrimidin-5-carbonsäuren und ihre Verwendung
|
DE102007061757A1
(de)
|
2007-12-20 |
2009-06-25 |
Bayer Healthcare Ag |
Substituierte 2-Phenylpyrimidin-5-carbonsäuren und ihre Verwendung
|
UA105362C2
(en)
|
2008-04-02 |
2014-05-12 |
Бьорингер Ингельхайм Интернациональ Гмбх |
1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
|
US9371311B2
(en)
|
2008-06-30 |
2016-06-21 |
Janssen Pharmaceutica Nv |
Benzoimidazol-2-yl pyrimidine derivatives
|
CN103319459A
(zh)
|
2008-06-30 |
2013-09-25 |
詹森药业有限公司 |
用于制备苯并咪唑-2-基嘧啶衍生物的方法
|
US8309720B2
(en)
|
2008-06-30 |
2012-11-13 |
Janssen Pharmaceutica Nv |
Process for the preparation of substituted pyrimidine derivatives
|
EP2344470B1
(en)
|
2008-09-02 |
2013-11-06 |
Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
EP2323622A1
(en)
|
2008-09-03 |
2011-05-25 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical formulations comprising the same
|
US9079905B2
(en)
|
2008-09-08 |
2015-07-14 |
Boehringer Ingelheim International Gmbh |
Compounds for the treatment of CNS disorders
|
EP2346505B1
(en)
|
2008-10-16 |
2014-04-23 |
Janssen Pharmaceuticals, Inc. |
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
|
CA2744138C
(en)
|
2008-11-28 |
2015-08-11 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
WO2010077613A1
(en)
*
|
2008-12-09 |
2010-07-08 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors
|
MY156377A
(en)
|
2009-03-31 |
2016-02-15 |
Boehringer Ingelheim Int |
1-heterocycl-1, 5-dihydro-pyrazolo [3 , 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
|
WO2010120237A1
(en)
*
|
2009-04-15 |
2010-10-21 |
Astrazeneca Ab |
Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
|
AU2010246607B2
(en)
|
2009-05-12 |
2012-09-27 |
Addex Pharma S.A. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
JO2907B1
(en)
|
2009-05-12 |
2015-09-15 |
اديكس فرما اس ايه |
Pyridine derivatives 1, 2, 4 trisolo [4, 3-A] and their uses as positive LLs for 2MGLUR receptors
|
CN102958933B
(zh)
|
2010-06-24 |
2016-02-03 |
吉里德科学公司 |
作为抗病毒药的吡唑并[1,5-a]嘧啶类
|
GEP20156217B
(en)
|
2010-08-12 |
2015-01-12 |
Boehringer Ingelheim Int |
6-cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors
|
AU2010363329A1
(en)
|
2010-11-07 |
2013-05-09 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
JP5852666B2
(ja)
|
2010-11-08 |
2016-02-03 |
ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド |
1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
|
CA2814996C
(en)
|
2010-11-08 |
2019-10-01 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
EP2643320B1
(en)
|
2010-11-08 |
2015-03-04 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
US8809345B2
(en)
|
2011-02-15 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
|
SG194131A1
(en)
|
2011-04-08 |
2013-11-29 |
Janssen R & D Ireland |
Pyrimidine derivatives for the treatment of viral infections
|
CN107011346B
(zh)
|
2011-11-09 |
2020-06-16 |
爱尔兰詹森科学公司 |
用于治疗病毒感染的嘌呤衍生物
|
EP2794611B1
(en)
|
2011-12-22 |
2017-10-11 |
Gilead Sciences, Inc. |
Pyrazolo[1,5-a]pyrimidines as antiviral agents
|
US9447051B2
(en)
*
|
2012-02-17 |
2016-09-20 |
Abbvie Inc. |
Diaminopyrimidines and uses thereof
|
WO2013146963A1
(ja)
|
2012-03-28 |
2013-10-03 |
武田薬品工業株式会社 |
複素環化合物
|
CN104583211A
(zh)
|
2012-04-17 |
2015-04-29 |
吉里德科学公司 |
用于抗病毒治疗的化合物和方法
|
NZ702364A
(en)
|
2012-07-13 |
2016-09-30 |
Janssen Sciences Ireland Uc |
Macrocyclic purines for the treatment of viral infections
|
PT2906563T
(pt)
|
2012-10-10 |
2018-05-23 |
Janssen Sciences Ireland Uc |
Derivados de pirrolo[3,2-d]pirimidina para o tratamento de infeções virais e outras doenças
|
JP6297055B2
(ja)
|
2012-11-16 |
2018-03-20 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
ウイルス感染症の治療のための複素環置換2−アミノ−キナゾリン誘導体
|
US9598378B2
(en)
*
|
2013-02-21 |
2017-03-21 |
Janssen Sciences Ireland Uc |
2-aminopyrimidine derivatives for the treatment of viral infections
|
RS59909B1
(sr)
|
2013-03-06 |
2020-03-31 |
Janssen Pharmaceutica Nv |
Benzoimidazol-2-il pirimidinski modulatori histaminskog h4 receptora
|
PT2978429T
(pt)
|
2013-03-29 |
2017-05-24 |
Janssen Sciences Ireland Uc |
Deaza-purinonas macrocíclicas para o tratamento de infeções virais
|
JP6377139B2
(ja)
|
2013-05-24 |
2018-08-22 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
ウイルス感染症およびさらなる疾患の処置のためのピリドン誘導体
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
US10385054B2
(en)
|
2013-06-27 |
2019-08-20 |
Janssen Sciences Ireland Unlimited Company |
Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
|
BR112016001570B1
(pt)
|
2013-07-30 |
2020-12-15 |
Janssen Sciences Ireland Uc |
Derivados de tieno[3,2-d]pirimidinas e composição farmacêutica que os compreende para o tratamento de infecções virais
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
CN109999025A
(zh)
|
2014-01-21 |
2019-07-12 |
詹森药业有限公司 |
包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途
|
IL279202B2
(en)
|
2014-01-21 |
2023-09-01 |
Janssen Pharmaceutica Nv |
Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use
|
MX2018009097A
(es)
*
|
2016-01-29 |
2019-03-06 |
Samjin Pharm Co Ltd |
Nuevo derivado de imidazol que tiene actividad inhibidora de jnk y uso del mismo.
|
MA45539A
(fr)
|
2016-07-01 |
2019-05-08 |
Janssen Sciences Ireland Unlimited Co |
Dihydropyranopyrimidines pour le traitement d'infections virales
|
US10968184B2
(en)
|
2016-09-29 |
2021-04-06 |
Janssen Sciences Ireland Unlimited Company |
Pyrimidine prodrugs for the treatment of viral infections and further diseases
|
TW201945003A
(zh)
|
2018-03-01 |
2019-12-01 |
愛爾蘭商健生科學愛爾蘭無限公司 |
2,4-二胺基喹唑啉衍生物及其醫學用途
|